Company: HSDTW
Filing Date: 2025-05-23
Form Type: S-1
Source: 0001104659-25-052494
Chunk: 18

Company: Solana Co
Filing Date: 2025-05-23
Form: S-1
Chunk 18
---
 a trading market, the liquidity of the common warrants and the pre-funded warrants will be extremely limited.

The number of shares of our common stock to be outstanding after this offering as shown above is based on 528,016 shares outstanding as of April 30, 2025, and excludes:

•

181,971 shares of our common stock issuable upon exercise of outstanding options at a weighted average exercise price of $112.73 per share;

•

513,402 shares of our common stock issuable upon exercise of outstanding warrants at a weighted average exercise price of $25.83 per share;

•

8,274 shares of our common stock to be reserved for potential future issuance pursuant to the Helius Medical Technologies, Inc. 2021 Inducement Plan (the “2021 Plan”) and the Helius Medical Technologies, Inc. 2022 Equity Incentive Plan (the “2022 Plan”); and

•

146,933 shares held in abeyance as of April 30, 2025, including 44,933 shares that were issued prior to May 23, 2025.

Unless otherwise indicated, this prospectus reflects and assumes the following:

•

no exercise of outstanding options or warrants after April 30, 2025 (including the common warrants, pre-funded warrants and Placement Agent Warrants offered hereby); and

•

no issuance of the shares of common stock issuable upon a “zero cash exercise” of the common warrants or the Placement Agent Warrants.

<div align='center'>8</div>

TABLE OF CONTENTS

### RISK FACTORS
An investment in our securities has a high degree of risk. Before you invest you should carefully consider the risks and uncertainties described below and in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2024, each of which is incorporated by reference herein, and the other information in this prospectus. Any of the risks and uncertainties set forth herein and therein could materially and adversely affect our business, results of operations and financial condition, which in turn could materially and adversely affect the trading price or value of our securities. Additional risks not currently known to us or which we consider immaterial based on information currently available to us may also materially adversely affect us. As a result, you could lose all or part of your investment.

Risks Relating to our Common Stock and this Offering

Nasdaq may delist our Common Stock for public interest concerns and we may be delisted if our stock